A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)(aEuro)

A. -M. C. Dingemans*, H. J. M. Groen, G. J. M. Herder, J. A. Stigt, E. F. Smit, I. Bahce, J. A. Burgers, B. E. E. M. van den Borne, B. Biesma, A. Vincent, V. van der Noort, J. G. Aerts

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2286-2293
JournalAnnals of Oncology
Volume26
Issue number11
DOIs
Publication statusPublished - Nov 2015

Keywords

  • nonsmall-cell lung cancer
  • nitroglycerin
  • bevacizumab
  • VEGF

Cite this